Gender Differences and Comorbidities in U.S. Adults with Bipolar Disorder.
- Authors
- Patel, Rikinkumar S; Virani, Sanya; Saeed, Hina; Nimmagadda, Sai; Talukdar, Jupi; Youssef, Nagy A
- Year
- 2018
- Journal
- Brain sciences
- PMID
- 30200460
- DOI
- 10.3390/brainsci8090168
- PMCID
- PMC6162692
BACKGROUND: Past studies have evaluated the association of various comorbidities with bipolar disorder. This study analyzes differences in the prevalence and association of medical and psychiatric comorbidities in bipolar patients by gender. METHODS: A retrospective analysis was conducted using the Nationwide Inpatient Sample (2010⁻2014). Using International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes, we narrowed the study population to comprise those with a primary diagnosis of bipolar disorder and then obtained information about comorbidities. The differences in comorbidities by gender were quantified using chi-square tests and the logistic regression model (odds ratio (OR)). RESULTS: Hypertension (20.5%), asthma (12.5%) and hypothyroidism (8.1%) were the top medical comorbidities found in bipolar patients. Migraine and hypothyroidism were seen three times higher in females (OR = 3.074 and OR = 3.001; respectively). Females with bipolar disorder had higher odds of comorbid inflammatory disorders like asthma (OR = 1.755), Crohn's disease (OR = 1.197) and multiple sclerosis (OR = 2.440) compared to males. Females had a two-fold higher likelihood of comorbid post-traumatic stress disorder (PTSD) (OR = 2.253) followed by personality disorders (OR = 1.692) and anxiety disorders (OR = 1.663) compared to males. CONCLUSION: Women with bipolar disorder have a much higher medical comorbidity burden than men and may highly benefit from an integrated team of physicians to manage their condition and improve their health-related quality of life.
Gender-wise distribution of comorbidities in patients with bipolar disorder. The proportion of males and females with bipolar disorder were obtained using cross tabulation and the Pearson Chi-Square (χ2) test, and were significant with p value ≤ 0.01 at a 95% confidence interval. PTSD: Post-traumatic stress disorder; ADHD: Attention-deficit/hyperactivity disorder.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Antidepressant use in older age bipolar disorder (OABD): Results from the GAGE-BD international consortium. | Rigas C et al. | — | 2026 | → |
| Clinical practice guidelines for the management of bipolar disorder: 2025 update. | Menon V et al. | — | 2026 | → |
| Family History and Solar Insolation in Bipolar I Disorder. | Bauer M et al. | — | 2026 | → |
| Altered White Matter Tracts in Bipolar Disorder: Insights from DTI Analysis | Mostafavi A et al. | — | 2025 | — |
| Gender Differences in Clinical and Biochemical Variables of Patients Affected by Bipolar Disorder. | Piccirilli L et al. | — | 2025 | → |
| Gender Differences in Prevalence and Clinical Correlates of Initial-Treatment and Drug-Naïve Bipolar Disorder Patients With Metabolic Syndrome: A Cross-Sectional Study. | Chen H et al. | — | 2025 | → |
| Long-Acting Injectable Antipsychotics in Adolescents with Bipolar Disorder. | Parikh P et al. | — | 2025 | → |
| Respiratory disease in people with bipolar disorder: a systematic review and meta-analysis. | Laguna-Muñoz D et al. | — | 2025 | → |
| The Role of Sex in Clinical Characteristics and Pharmacological Treatment of Bipolar Disorder. | Putz E et al. | — | 2025 | → |
| Tracking complete blood count-derived indices during transition to euthymia in bipolar disorder: a longitudinal study. | Gökçen O et al. | — | 2025 | → |
| Sex differences in bipolar disorder: The dorsolateral prefrontal cortex as an etiopathogenic region. | Zhang L et al. | — | 2024 | → |
| The Effect of Omega-3 Supplementation on Serum Levels of Antioxidant Status in Patients With Bipolar Disease: A Randomized Double-blind Controlled Clinical Trial. | Gholipour D et al. | — | 2024 | → |
| The neuropsychological presentation of women with epilepsy: Clinical considerations and future directions. | Lorkiewicz SA et al. | — | 2024 | → |
| Transcriptomic sex differences in postmortem brain samples from patients with psychiatric disorders. | Xia Y et al. | — | 2024 | → |
| A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset. | Preuss UW et al. | — | 2023 | → |
| Bipolar affective disorder in India: A multi-site population-based cross-sectional study. | Vajawat B et al. | — | 2023 | → |
| Clinical characterization of patients with bipolar disorder and a history of asthma: An exploratory study. | Romo-Nava F et al. | — | 2023 | → |
| Nurse views of obstacles encountered by nurses in Saudi Arabia during the provision of psychiatric care. | Alyousef SM et al. | — | 2023 | → |
| Optimizing multi-domain hematologic biomarkers and clinical features for the differential diagnosis of unipolar depression and bipolar depression. | Zeng J et al. | — | 2023 | → |
| Racial and gender-based disparities and trends in common psychiatric conditions in liver cirrhosis hospitalizations: A ten-year United States study. | Patel P et al. | — | 2023 | → |
| Sex-Based Differences and Risk Factors for Comorbid Nonalcoholic Fatty Liver Disease in Patients with Bipolar Disorder: A Cross-Sectional Retrospective Study. | Wang Y et al. | — | 2023 | → |
| Sex-specific risk profiles for suicide mortality in bipolar disorder: incidence, healthcare utilization and comorbidity. | Chen PH et al. | — | 2023 | → |
| Age-related changes in physiology in individuals with bipolar disorder. | Mutz J et al. | — | 2022 | → |
| Clinical profiles of subsequent stages in bipolar disorder: Results from the Dutch Bipolar Cohort. | van der Markt A et al. | — | 2022 | → |
| Mapping multimorbidity in individuals with schizophrenia and bipolar disorders: evidence from the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register. | Bendayan R et al. | — | 2022 | → |
| Social Determinants of Health and Comorbidities Among Individuals with Atherosclerotic Cardiovascular Disease: The Behavioral Risk Factor Surveillance System Survey. | Al Rifai M et al. | — | 2022 | → |
| The prevalence and clinical correlates of medical disorders comorbidities in patients with bipolar disorder. | Wang Z et al. | — | 2022 | → |
| Gender Differences in Complete Blood Count and Inflammatory Ratios among Patients with Bipolar Disorder. | Fusar-Poli L et al. | — | 2021 | → |
| Access to care barriers for patients with Bipolar disorder in the United States. | Crusey A et al. | — | 2020 | → |
| Anesthesia for patients with psychiatric illnesses: a narrative review with emphasis on preoperative assessment and postoperative recovery and pain. | Stamenkovic DM et al. | — | 2020 | → |
| Combination Regimen With Lithium and Antipsychotic in Bipolar Manic Episodes: Impact on Adult Hospitalization Length of Stay. | Lee HK et al. | — | 2020 | → |
| Gender and mental health service use in bipolar disorder: national cohort study. | Cunningham R et al. | — | 2020 | → |
| Predictors for Extending Hospitalization Stay in Electroconvulsive Therapy Recipients With Bipolar Disorder, Manic Episodes. | Bodicherla KP et al. | — | 2020 | → |
| A population-based heritability estimate of bipolar disorder - In a Swedish twin sample. | Johansson V et al. | — | 2019 | → |
| Bipolar Disorder and Comorbid Borderline Personality Disorder: Patient Characteristics and Outcomes in US Hospitals. | Patel RS et al. | — | 2019 | → |
| Medical and Psychiatric Comorbidities in Bipolar Disorder: Insights from National Inpatient Population-based Study. | Hossain S et al. | — | 2019 | → |